SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-22-040167
Filing Date
2022-03-30
Accepted
2022-03-30 16:40:59
Documents
68
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K rgrx-20211231x10k.htm   iXBRL 10-K 1806860
2 EXHIBIT 23.1 rgrx-20211231xex23d1.htm EX-23.1 2962
3 EXHIBIT 31.1 rgrx-20211231xex31d1.htm EX-31.1 7704
4 EXHIBIT 32.1 rgrx-20211231xex32d1.htm EX-32.1 5536
  Complete submission text file 0001104659-22-040167.txt   6693894

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20211231.xsd EX-101.SCH 50103
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20211231_cal.xml EX-101.CAL 52710
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20211231_def.xml EX-101.DEF 141064
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20211231_lab.xml EX-101.LAB 352841
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20211231_pre.xml EX-101.PRE 310114
62 EXTRACTED XBRL INSTANCE DOCUMENT rgrx-20211231x10k_htm.xml XML 1072006
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15070 | Film No.: 22787083
SIC: 2834 Pharmaceutical Preparations